TrialSite has reported on a few different study results indicating that Roche’s Actemra (tocilizumab), an IL-6 inhibitor, doesn’t help to lower […]
TrialSite recently suggested based on unfolding study results that repurposed IL-6 inhibitors, such as Roche’s Actemra®/ReActemtra® (tocilizumab), may not work to […]
200 mg vial Tocilizumab—15,000 Rs ($200.20)
400 mg vial Tocilizumab—30,000 Rs ($400.39)
Full Itolizumab Treatment—40,000 rupees
Baylor College of Medicine is a clinical investigational site for a clinical trial investigating the therapeutic benefits of an immunomodulator […]
Roche recently announce the launch of a global study in collaboration with the U.S. Biomedical Advanced Research and Development Authority […]
The potential of Ivermectin as a treatment for COVID-19 has gained more attention of late since the meta-analysis led by Dr. […]
Known as the MENA region, the Middle East and Northern Africa, Arabian Business recently elaborated on the various COVID-19 therapies […]
Xolair is the first biologic for the treatment of nasal polyps that targets and blocks immunoglobulin E (IgE), a key […]
TrialSite recently reported that the independent data monitoring committee recommended to continue the Montreal Heart Institute study investigating the use of […]
On November 13, a scientific review manuscript was posted to OSF, a medical pre-print server by Pierre Kory, MD, of […]
